Met Life Investment Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 55,182 shares of LXRX stock, worth $45,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,182

Previous 55,182 -0.0%

Holding current value

$45,801

Previous $92,000 6.52%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.54 - $2.28 $34,372 - $50,889	22,320 Added 67.92%	55,182 $92,000
Q1 2024 May 14, 2024	BUY	$1.3 - $3.58 $42,720 - $117,645	32,862 New	32,862 $78,000
Q2 2023 Apr 29, 2024	BUY	$2.15 - $3.49 $92,093 - $149,490	42,834 New	42,834 $98,000
Q1 2023 May 09, 2024	BUY	$1.99 - $2.68 $85,239 - $114,795	42,834 New	42,834 $104 Million
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $41,788 - $56,277	20,999 Added 96.17%	42,834 $104,000
Q4 2022 May 10, 2024	SELL	$1.8 - $2.56 $32,797 - $46,645	-18,221 Reduced 45.49%	21,835 $41,000
Q4 2022 Jun 14, 2023	SELL	$1.8 - $2.56 $37,798 - $53,757	-20,999 Reduced 49.02%	21,835 $41,000
Q4 2022 Mar 22, 2023	SELL	$1.8 - $2.56 $32,797 - $46,645	-18,221 Reduced 45.49%	21,835 $41,000
Q4 2022 Feb 15, 2023	SELL	$1.8 - $2.56 $32,797 - $46,645	-18,221 Reduced 45.49%	21,835 $41,000
Q3 2022 May 10, 2024	BUY	$1.94 - $3.43 $77,708 - $137,392	40,056 New	40,056 $96,000
Q3 2022 Jun 14, 2023	SELL	$1.94 - $3.43 $5,389 - $9,528	-2,778 Reduced 6.49%	40,056 $96,000
Q3 2022 Mar 22, 2023	BUY	$1.94 - $3.43 $28,036 - $49,570	14,452 Added 56.44%	40,056 $96,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $77,708 - $137,392	40,056 New	40,056 $96,000
Q1 2022 May 12, 2022	SELL	$1.95 - $3.89 $49,927 - $99,599	-25,604 Closed	0 $0
Q4 2021 Jun 21, 2023	SELL	$3.81 - $6.16 $65,646 - $106,136	-17,230 Reduced 40.23%	25,604 $100,000
Q3 2021 May 17, 2024	SELL	$3.38 - $5.35 $24,532 - $38,830	-7,258 Reduced 22.09%	25,604 $123,000
Q3 2021 Jun 21, 2023	SELL	$3.38 - $5.35 $58,237 - $92,180	-17,230 Reduced 40.23%	25,604 $123,000
Q3 2021 Mar 22, 2023	BUY	$3.38 - $5.35 $5,952 - $9,421	1,761 Added 7.39%	25,604 $123,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $86,541 - $136,981	25,604 New	25,604 $123,000
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $28,611 - $158,794	-23,843 Closed	0 $0
Q2 2019 Jul 12, 2023	SELL	$5.35 - $7.11 $101,601 - $135,026	-18,991 Reduced 44.34%	23,843 $149,000
Q1 2019 Jul 13, 2023	SELL	$4.36 - $7.94 $82,800 - $150,788	-18,991 Reduced 44.34%	23,843 $132,000
Q4 2018 Jul 13, 2023	SELL	$6.15 - $10.51 $116,794 - $199,595	-18,991 Reduced 44.34%	23,843 $158,000
Q4 2018 Mar 22, 2023	SELL	$6.15 - $10.51 $72,951 - $124,669	-11,862 Reduced 33.22%	23,843 $158,000
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $72,951 - $124,669	-11,862 Reduced 33.22%	23,843 $158,000
Q3 2018 Jul 13, 2023	SELL	$10.32 - $13.06 $195,987 - $248,022	-18,991 Reduced 44.34%	23,843 $254,000
Q3 2018 Mar 22, 2023	BUY	$10.32 - $13.06 $143,138 - $181,142	13,870 Added 63.52%	35,705 $380,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $122,415 - $154,917	11,862 Added 49.75%	35,705 $381,000
Q4 2017 Feb 15, 2018	BUY	$8.77 - $12.28 $209,103 - $292,792	23,843	23,843 $236,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Lexicon Pharmaceuticals, Inc. Transaction History